HTA Innovation
Valuing Innovation Project
Innovation in health technologies (both pharmaceutical and non-pharmaceutical) has substantively improved life expectancy and quality of life in recent decades. However, as biomedical and digital innovations accelerate in healthcare across disease states, the methods and practices to define, measure, and reward innovation in the context of Health Technology Assessment (HTA) are not keeping pace. Growing pressure to demonstrate the “value” of new health technologies—along with recent updates in HTA frameworks—mandates a more comprehensive set of attributes to define and measure the innovative properties of novel health technologies.
Advancing the Field
With our multi-stakeholder partners, the Center for Innovation & Value Research launched the Valuing Innovation Project (VIP), a multi-phase initiative to advance the dialogue, identify gaps in current HTA approaches, and build consensus on practical methods to better measure and reward innovation.
Project Objectives
Define
innovation in the context of HTA and articulate the need to develop process, methods, and data improvements
Prioritize
areas for HTA methods exploration and applied research needed to improve how HTA can better account for innovation across different technology types
Identify
innovative solutions to address prioritized research areas, focusing on actionable strategies that the Center and different stakeholders in the health system can take to accelerate change and share learning on these improvements
Project Co-Chairs
Award Winners
The Center for Innovation & Value Research is pleased to announce the 2023 Valuing Innovation Project (VIP) Call for Papers awardees.
This year’s recipients presented innovative ideas that addressed vital research questions in Health Technology Assessment (HTA), ranging from scientific spillovers to real option values to the impacts of innovation on the broader society.